Direxion Daily S&P Biotech Bear 3X ETF

MicroSectors Gold Miners 3X Leveraged ETN

Direxion Daily Gold Miners Bull 3X ETF

VS TR 2x Long VIX Futures ETF

VanEck Vectors Junior Gold Miners ETF

ProShares Ultra DJ-AIG Crude Oi

ProShares Ultra VIX Short-Term Futures

ProShares Ultra Silver

ProShares UltraShort Bloomberg Natrl Gas

VanEck Vectors Gold Miners ETF

Direxion Daily S&P Biotech Bull 3X ETF

MicroSectors Gold Miners -3X Inverse Leveraged ETNs

SPDR S&P Biotech ETF

Altimmune Inc. Common Stock

Direxion Daily Gold Miners Bear 3X ETF

iShares Nasdaq Biotechnology

AXS 2X Innovation ETF

ProShares UltraShort Silver

ProShares Ultra Bloomberg Natural Gas

ARK Innovation ETF

Pony AI Inc. American Depositary Shares

EVgo Inc. Class A Common Stock

CorMedix Inc. Common Stock

Hims & Hers Health Inc. Class A Common Stock

Resideo Technologies Inc. Common Stock

Oklo Inc.

SolarEdge Technologies Inc. Common Stock

Premier Inc. Class A Common Stock

Constellation Energy Corporation Common Stock

CVR Energy Inc. Common Stock

Zoomcar Holdings Inc. Common Stock

Polyrizon Ltd. Ordinary Shares

Hyperscale Data Inc. Common Stock

JELD-WEN Holding Inc. Common Stock

Upstart Holdings Inc. Common stock

Firefly Neuroscience Inc. Common Stock

DigitalOcean Holdings Inc. Common Stock

Palantir Technologies Inc. Class A Common Stock

Moderna Inc. Common Stock

CRISPR Therapeutics AG Common Shares

Click here to get full coverage on Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025 - GlobeNewswire

Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025  GlobeNewswire

Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025 - GlobeNewswire

Click here to get full coverage on Vuori announces first Ohio location in Woodmere at Eton Chagrin Boulevard - WKYC

Vuori announces first Ohio location in Woodmere at Eton Chagrin Boulevard  WKYC

Vuori announces first Ohio location in Woodmere at Eton Chagrin Boulevard - WKYC

Click here to get full coverage on Eton Pharmaceuticals, Inc. (ETON) Earnings Expected to Grow: What to Know Ahead of Q1 Release - Yahoo Finance

Eton Pharmaceuticals, Inc. (ETON) Earnings Expected to Grow: What to Know Ahead of Q1 Release  Yahoo Finance

Eton Pharmaceuticals, Inc. (ETON) Earnings Expected to Grow: What to Know Ahead of Q1 Release - Yahoo Finance

Click here to get full coverage on Eton Pharmaceuticals to Report Q1 2025 Financial Results on May 13, 2025 - Nasdaq

Eton Pharmaceuticals to Report Q1 2025 Financial Results on May 13, 2025  Nasdaq

Eton Pharmaceuticals to Report Q1 2025 Financial Results on May 13, 2025 - Nasdaq

Click here to get full coverage on Eton-Harrow match at Lord’s clashes with exam timetable - The Times

Eton-Harrow match at Lord’s clashes with exam timetable  The Times

Eton-Harrow match at Lord’s clashes with exam timetable - The Times

Click here to get full coverage on Revitalization efforts coming to Eton Square - fox23.com

Revitalization efforts coming to Eton Square  fox23.com

Revitalization efforts coming to Eton Square - fox23.com

Click here to get full coverage on Is Prince George going to Eton? Prince William and the Princess of Wales have made ‘secret visits’ to the school, sources say, as speculation about the royal’s next move ramps up - Tatler

Is Prince George going to Eton? Prince William and the Princess of Wales have made ‘secret visits’ to the school, sources say, as speculation about the royal’s next move ramps up  Tatler

Is Prince George going to Eton? Prince William and the Princess of Wales have made ‘secret visits’ to the school, sources say, as speculation about the royal’s next move ramps up - Tatler

Click here to get full coverage on Turnbridge Equities Acquires Eton Industrial Park in Los Angeles, CA for $28 Million - Business Wire

Turnbridge Equities Acquires Eton Industrial Park in Los Angeles, CA for $28 Million  Business Wire

Turnbridge Equities Acquires Eton Industrial Park in Los Angeles, CA for $28 Million - Business Wire

Click here to get full coverage on Eton Pharmaceuticals Announces Submission of NDA for ET-600 (Desmopressin Oral Solution) - GlobeNewswire

Eton Pharmaceuticals Announces Submission of NDA for ET-600 (Desmopressin Oral Solution)  GlobeNewswire

Eton Pharmaceuticals Announces Submission of NDA for ET-600 (Desmopressin Oral Solution) - GlobeNewswire

Click here to get full coverage on Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Has Found A Path To Profitability - Yahoo Finance

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Has Found A Path To Profitability  Yahoo Finance

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Has Found A Path To Profitability - Yahoo Finance

Click here to get full coverage on Eton Pharmaceuticals Reports Fourth Quarter 2024 Financial Results - GlobeNewswire

Eton Pharmaceuticals Reports Fourth Quarter 2024 Financial Results  GlobeNewswire

Eton Pharmaceuticals Reports Fourth Quarter 2024 Financial Results - GlobeNewswire

Click here to get full coverage on Eton Pharmaceuticals Out-Licenses International Rights to Increlex® - GlobeNewswire

Eton Pharmaceuticals Out-Licenses International Rights to Increlex®  GlobeNewswire

Eton Pharmaceuticals Out-Licenses International Rights to Increlex® - GlobeNewswire

Click here to get full coverage on Eton Pharmaceuticals Announces Commercial Launch of Galzin® (zinc acetate) Capsules - GlobeNewswire

Eton Pharmaceuticals Announces Commercial Launch of Galzin® (zinc acetate) Capsules  GlobeNewswire

Eton Pharmaceuticals Announces Commercial Launch of Galzin® (zinc acetate) Capsules - GlobeNewswire

Click here to get full coverage on Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600 - GlobeNewswire

Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600  GlobeNewswire

Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600 - GlobeNewswire

Click here to get full coverage on Optime Care Partners with Eton Pharmaceuticals as a Specialty Pharmacy Provider for GALZIN® - GlobeNewswire

Optime Care Partners with Eton Pharmaceuticals as a Specialty Pharmacy Provider for GALZIN®  GlobeNewswire

Optime Care Partners with Eton Pharmaceuticals as a Specialty Pharmacy Provider for GALZIN® - GlobeNewswire

Click here to get full coverage on Eton Pharmaceuticals Announces Extension of PDUFA Goal Date for ET-400 - GlobeNewswire

Eton Pharmaceuticals Announces Extension of PDUFA Goal Date for ET-400  GlobeNewswire

Eton Pharmaceuticals Announces Extension of PDUFA Goal Date for ET-400 - GlobeNewswire

Click here to get full coverage on Eton Pharmaceuticals Advances Its Commitment to Rare Disease with the Acquisition of Galzin® - GlobeNewswire

Eton Pharmaceuticals Advances Its Commitment to Rare Disease with the Acquisition of Galzin®  GlobeNewswire

Eton Pharmaceuticals Advances Its Commitment to Rare Disease with the Acquisition of Galzin® - GlobeNewswire

Click here to get full coverage on Eton Pharmaceuticals Expands Patent Portfolio with Issuance of New U.S. Patent for ET-600 - GlobeNewswire

Eton Pharmaceuticals Expands Patent Portfolio with Issuance of New U.S. Patent for ET-600  GlobeNewswire

Eton Pharmaceuticals Expands Patent Portfolio with Issuance of New U.S. Patent for ET-600 - GlobeNewswire

Click here to get full coverage on Eton Pharmaceuticals to Host Virtual Investor Day and Release Fourth Quarter Earnings Results on March 18, 2025 - GlobeNewswire

Eton Pharmaceuticals to Host Virtual Investor Day and Release Fourth Quarter Earnings Results on March 18, 2025  GlobeNewswire

Eton Pharmaceuticals to Host Virtual Investor Day and Release Fourth Quarter Earnings Results on March 18, 2025 - GlobeNewswire

Click here to get full coverage on Eton Pharmaceuticals Closes Acquisition of Increlex® (mecasermin injection) - GlobeNewswire

Eton Pharmaceuticals Closes Acquisition of Increlex® (mecasermin injection)  GlobeNewswire

Eton Pharmaceuticals Closes Acquisition of Increlex® (mecasermin injection) - GlobeNewswire

Click here to get full coverage on Eton secures US patent for diabetes insipidus treatment - Pharmaceutical Technology

Eton secures US patent for diabetes insipidus treatment  Pharmaceutical Technology

Eton secures US patent for diabetes insipidus treatment - Pharmaceutical Technology

Click here to get full coverage on Eton Pharmaceuticals, Inc. (ETON) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance

Eton Pharmaceuticals, Inc. (ETON) Reports Q4 Loss, Tops Revenue Estimates  Yahoo Finance

Eton Pharmaceuticals, Inc. (ETON) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance

Click here to get full coverage on Eton Solutions, the Leading WealthTech Platform Powered by AI, Partners with Trigen Wealth, a Newly Launched Full Service Multi-Family Office in India - Business Wire

Eton Solutions, the Leading WealthTech Platform Powered by AI, Partners with Trigen Wealth, a Newly Launched Full Service Multi-Family Office in India  Business Wire

Eton Solutions, the Leading WealthTech Platform Powered by AI, Partners with Trigen Wealth, a Newly Launched Full Service Multi-Family Office in India - Business Wire

Click here to get full coverage on Eton Solutions Launches EtonGPT™ Enabled Fund Accounting Platform and Services Targeted at General Partners of Private Equity Firms - Business Wire

Eton Solutions Launches EtonGPT™ Enabled Fund Accounting Platform and Services Targeted at General Partners of Private Equity Firms  Business Wire

Eton Solutions Launches EtonGPT™ Enabled Fund Accounting Platform and Services Targeted at General Partners of Private Equity Firms - Business Wire

Click here to get full coverage on Eton Pharmaceuticals acquires FDA-approved Wilson disease drug Galzin - World Pharmaceutical Frontiers

Eton Pharmaceuticals acquires FDA-approved Wilson disease drug Galzin  World Pharmaceutical Frontiers

Eton Pharmaceuticals acquires FDA-approved Wilson disease drug Galzin - World Pharmaceutical Frontiers

Click here to get full coverage on Ye's Net Worth Confirmed at $2.77 Billion by Eton Venture Services - PR Newswire

Ye's Net Worth Confirmed at $2.77 Billion by Eton Venture Services  PR Newswire

Ye's Net Worth Confirmed at $2.77 Billion by Eton Venture Services - PR Newswire

Click here to get full coverage on Eton Pharmaceuticals Reports Third Quarter 2024 Financial Results - GlobeNewswire

Eton Pharmaceuticals Reports Third Quarter 2024 Financial Results  GlobeNewswire

Eton Pharmaceuticals Reports Third Quarter 2024 Financial Results - GlobeNewswire

Click here to get full coverage on Eton Pharmaceuticals Announces Acquisition of U.S. Rights to Amglidia (Glyburide Oral Suspension) - GlobeNewswire

Eton Pharmaceuticals Announces Acquisition of U.S. Rights to Amglidia (Glyburide Oral Suspension)  GlobeNewswire

Eton Pharmaceuticals Announces Acquisition of U.S. Rights to Amglidia (Glyburide Oral Suspension) - GlobeNewswire

Click here to get full coverage on Eton Pharmaceuticals Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

Eton Pharmaceuticals Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags  Yahoo Finance

Eton Pharmaceuticals Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

Click here to get full coverage on Eton Pharmaceuticals Announces Final Readout of PKU GOLIKE® Clinical Trial - GlobeNewswire

Eton Pharmaceuticals Announces Final Readout of PKU GOLIKE® Clinical Trial  GlobeNewswire

Eton Pharmaceuticals Announces Final Readout of PKU GOLIKE® Clinical Trial - GlobeNewswire

Click here to get full coverage on Fiamma by Mendel fires up in Eton Chagrin Boulevard (photos) - Cleveland.com

Fiamma by Mendel fires up in Eton Chagrin Boulevard (photos)  Cleveland.com

Fiamma by Mendel fires up in Eton Chagrin Boulevard (photos) - Cleveland.com

Click here to get full coverage on Eton's Pediatric Rare Disease Drug Faces 3-Month FDA Review Extension - Revenue Outlook Unchanged - Stock Titan

Eton's Pediatric Rare Disease Drug Faces 3-Month FDA Review Extension - Revenue Outlook Unchanged  Stock Titan

Eton's Pediatric Rare Disease Drug Faces 3-Month FDA Review Extension - Revenue Outlook Unchanged - Stock Titan

Click here to get full coverage on My Eton tormentor has been jailed - The Spectator

My Eton tormentor has been jailed  The Spectator

My Eton tormentor has been jailed - The Spectator

Click here to get full coverage on Eton acquires US rights to neonatal diabetes treatment from AMMTeK - Pharmaceutical Technology

Eton acquires US rights to neonatal diabetes treatment from AMMTeK  Pharmaceutical Technology

Eton acquires US rights to neonatal diabetes treatment from AMMTeK - Pharmaceutical Technology

Click here to get full coverage on Kate Middleton Tries To Keep Prince George Away From Eton College - The Royal Observer

Kate Middleton Tries To Keep Prince George Away From Eton College  The Royal Observer

Kate Middleton Tries To Keep Prince George Away From Eton College - The Royal Observer

Click here to get full coverage on Eton Pharmaceuticals Awarded Second Patent for ET-400 (Hydrocortisone Oral Solution) - GlobeNewswire

Eton Pharmaceuticals Awarded Second Patent for ET-400 (Hydrocortisone Oral Solution)  GlobeNewswire

Eton Pharmaceuticals Awarded Second Patent for ET-400 (Hydrocortisone Oral Solution) - GlobeNewswire

Click here to get full coverage on How Beatlemania helped sell Eton Shirts - The Drum

How Beatlemania helped sell Eton Shirts  The Drum

How Beatlemania helped sell Eton Shirts - The Drum

Click here to get full coverage on Prince George on Cusp of Major Life Decision - Newsweek

Prince George on Cusp of Major Life Decision  Newsweek

Prince George on Cusp of Major Life Decision - Newsweek

Click here to get full coverage on Swedish Men’s Brand Eton Opening New Concept Flagship on Madison Avenue - WWD

Swedish Men’s Brand Eton Opening New Concept Flagship on Madison Avenue  WWD

Swedish Men’s Brand Eton Opening New Concept Flagship on Madison Avenue - WWD

Click here to get full coverage on News | Eton College does the maths on major South East mall acquisition - CoStar

News | Eton College does the maths on major South East mall acquisition  CoStar

News | Eton College does the maths on major South East mall acquisition - CoStar

Click here to get full coverage on If Eton can do it … Public speaking advice from state-educated experts - The Guardian

If Eton can do it … Public speaking advice from state-educated experts  The Guardian

If Eton can do it … Public speaking advice from state-educated experts - The Guardian

Click here to get full coverage on Eton among elite private schools set to cash in on windfall from new VAT rules - The Guardian

Eton among elite private schools set to cash in on windfall from new VAT rules  The Guardian

Eton among elite private schools set to cash in on windfall from new VAT rules - The Guardian

Click here to get full coverage on Eton to raise fees to £63,000 per annum in response to VAT change | Private schools - The Guardian

Eton to raise fees to £63,000 per annum in response to VAT change | Private schools  The Guardian

Eton to raise fees to £63,000 per annum in response to VAT change | Private schools - The Guardian

Click here to get full coverage on Our only son died at Eton. This is why we want to talk about it - The Times

Our only son died at Eton. This is why we want to talk about it  The Times

Our only son died at Eton. This is why we want to talk about it - The Times

Click here to get full coverage on The Eton boys putting on million pound parties - The Times

The Eton boys putting on million pound parties  The Times

The Eton boys putting on million pound parties - The Times

Click here to get full coverage on ‘VAT is a mistake: 100 Eton parents say it’s going to be difficult’ - The Times

‘VAT is a mistake: 100 Eton parents say it’s going to be difficult’  The Times

‘VAT is a mistake: 100 Eton parents say it’s going to be difficult’ - The Times

Click here to get full coverage on New students at Eton, the poshest of Britain's elite private schools, will not be allowed smartphones - CBS News

New students at Eton, the poshest of Britain's elite private schools, will not be allowed smartphones  CBS News

New students at Eton, the poshest of Britain's elite private schools, will not be allowed smartphones - CBS News

Click here to get full coverage on Windsor & Eton Brewery | Crowdfunding Investment | Seedrs - Republic Europe

Windsor & Eton Brewery | Crowdfunding Investment | Seedrs  Republic Europe

Windsor & Eton Brewery | Crowdfunding Investment | Seedrs - Republic Europe

Click here to get full coverage on Eton’s Ethically Equivocal Entrance Exam Essay - Ordinary Times

Eton’s Ethically Equivocal Entrance Exam Essay  Ordinary Times

Eton’s Ethically Equivocal Entrance Exam Essay - Ordinary Times

Click here to get full coverage on Eton to Charge Parents Full 20% VAT on School Fees in January - Bloomberg

Eton to Charge Parents Full 20% VAT on School Fees in January  Bloomberg

Eton to Charge Parents Full 20% VAT on School Fees in January - Bloomberg

Click here to get full coverage on Music teacher at £53,000-a-year Eton College is handed lifetime classroom ban after being caught searching for - Daily Mail

Music teacher at £53,000-a-year Eton College is handed lifetime classroom ban after being caught searching for  Daily Mail

Music teacher at £53,000-a-year Eton College is handed lifetime classroom ban after being caught searching for - Daily Mail

Click here to get full coverage on Eton and smartphones: how effective is a mobile ban in schools? - Tortoise Media

Eton and smartphones: how effective is a mobile ban in schools?  Tortoise Media

Eton and smartphones: how effective is a mobile ban in schools? - Tortoise Media

Click here to get full coverage on My shock when I learnt my old Eton master’s set included paedophiles - The Times

My shock when I learnt my old Eton master’s set included paedophiles  The Times

My shock when I learnt my old Eton master’s set included paedophiles - The Times

Click here to get full coverage on Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-400 (Hydrocortisone Oral Solution) - GlobeNewswire

Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-400 (Hydrocortisone Oral Solution)  GlobeNewswire

Eton Pharmaceuticals Inc (ETON)

Price Chart

Key Statistics

Technicals

About ETON

Latest News

Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025 - GlobeNewswire

Vuori announces first Ohio location in Woodmere at Eton Chagrin Boulevard - WKYC

Eton Pharmaceuticals, Inc. (ETON) Earnings Expected to Grow: What to Know Ahead of Q1 Release - Yahoo Finance

Advanced Charts

Top Gainers

Top Losers